We are live on ! Find out more
BVS icon

Bioventus

69 hedge funds and large institutions have $352M invested in Bioventus in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 30 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

266% more capital inflows, than outflows

Capital inflows: $84.8M | Capital outflows: $23.2M

229% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 7

114% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 14

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

30% more funds holding

Funds holding: 53 → 69 (+16)

10.04% more ownership

Funds ownership: 50.48% → 60.51% (+10%)

Holders
69
Holders Change
+16
Holders Change %
+30.19%
% of All Funds
1.2%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
23
Increased
30
Reduced
14
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

BVS Hedge Fund Activity: Q3 2021 in Review

69 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q3 2021, worth a combined $352M — down 3.5% from $364M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new BVS positions and 7 closed out — a net gain of 16 holders — while 30 added to existing stakes and 14 trimmed.

The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $41.2M. The largest seller was Deerfield Management, exiting entirely with an estimated $13.7M sold.

  • 69 institutional investors held Bioventus (BVS) as of Q3 2021, up from 53 in Q2 2021.
  • Funds reported $352M of Bioventus stock for Q3 2021, down 3.5% quarter-over-quarter.
  • 23 funds opened new Bioventus positions in Q3 2021 and 7 closed out, a net change of +16 holders.
  • The largest Bioventus buyer in Q3 2021 was T. Rowe Price Associates, an estimated $41.2M added.
  • The largest Bioventus seller in Q3 2021 was Deerfield Management, an estimated $13.7M sold.

Based on aggregated 13F filings for Q3 2021.